Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
University Of California Researchers Develop New Enzyme Linked to Cell Growth, Cancer
A team of scientists from the University of California has made a groundbreaking discovery regarding ZCCHC4, an innovative enzyme responsible for modifying RNA molecules....
The University of Bath Researchers Develop New Saliva Test to Detect Synthetic Drug
A simple saliva test has been developed by the researchers at the University of Bath to detect if someone has recently taken the street drug ‘spice’. The substance known as ‘spice’, is usually a mixture of dried and shredded plant material, sprayed with various synthetic chemicals meant to mimic the main component of cannabis....
Mirum Pharmaceuticals Launch New Drug for Treatment of Alagille Syndrome
Mirum Pharmaceuticals has recently introduced a new medication called Maralixibat, designed for the treatment of pruritus (itching) associated with Alagille syndrome (ALGS) in patients aged one year and older....
Eli Lilly Launch New Drug to Treat Acute Migraine in Adults
A new oral medication, REYVOW™ (lasmiditan) has been launched by Eli Lilly and Company for the treatment of acute migraine, with or without aura, in adults....
New Oral Inhibitor Launched to Treat Patients with Histiocytic Neoplasms
A new oral inhibitor, cobimetinib (Cotellic) has been launched by the Memorial Sloan Kettering Cancer Center (MSK) for the treatment of adult patients with histolytic neoplasms (HN) (Erdheim-Chester Disease, Rosai-Dorfman, Langerhans Histiocytosis)....
Janssen Pharma’s Niraparib Treats Patients with Prostate Cancer
The PARP inhibitor is used to treat patients with BRCA 1/2 gene-mutated metastatic castration-resistant prostate cancer (mCRPC) and DNA repair gene defects (DRD). The BRCA 1/2 mutations are the most common DRD in patients with mCRPC....
UC Santa Cruz Researchers Develop Novel Nanoprobes
A new ultrasensitive nanoscale optical probe has been developed by the researchers at UC Santa Cruz that can monitor the bioelectric activity of neurons and other excitable cells....
Boehringer Ingelheim Launches Breakthrough Medication for Treatment of ILDs
A new medication, Ofev® (nintedanib) has been launched by Boehringer Ingelheim for the treatment of patients with chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype....
Roche's New Lymphoma Medicine to Treat Lupus Nephritis
Genentech, a member of the Roche Group, has introduced a groundbreaking medicine called Gazyva® (obinutuzumab) for the treatment of lupus nephritis in adults....
Breakthrough Drug Launched to Treat Desmoid Tumors in Adult Patients
SpringWorks Therapeutics has introduced an experimental drug called nirogacestat for the treatment of rare and progressive cancer called desmoid tumors in adult patients....
